Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

henry schein inc. - HSIC

HSIC

Close Chg Chg %
73.77 1.31 1.78%

Closed Market

75.08

+1.31 (1.78%)

Volume: 3.38M

Last Updated:

Nov 22, 2024, 4:00 PM EDT

Trade Now

Company Overview: henry schein inc. - HSIC

HSIC Key Data

Open

$74.24

 Day Range

73.25 - 75.18

52 Week Range

63.69 - 82.63

 Market Cap

$9.20B

Shares Outstanding

124.68M

 Public Float

123.01M

Beta

0.87

 Rev. Per Employee

N/A

P/E Ratio

30.21

 EPS

$2.46

Yield

0.00%

 Dividend

$17.22

EX-DIVIDEND DATE

Feb 8, 2019

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.98M

  

HSIC Performance

1 Week
 
 9.19%
 
1 Month
 
 7.26%
 
3 Months
 
 6.02%
 
1 Year
 
 7.77%
 
5 Years
 
 8.34%
 

HSIC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 14
Full Ratings ➔

About henry schein inc. - HSIC

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

HSIC At a Glance

Henry Schein, Inc.
135 Duryea Road
Melville, New York 11747
Phone 1-631-843-5500 Revenue 12.34B
Industry Medical Distributors Net Income 416.00M
Sector Distribution Services Employees 25,000
Fiscal Year-end 12 / 2024
View SEC Filings

HSIC Valuation

P/E Current 30.21
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 23.978
Price to Sales Ratio 0.808
Price to Book Ratio 2.677
Price to Cash Flow Ratio 19.949
Enterprise Value to EBITDA 14.597
Enterprise Value to Sales 1.138
Total Debt to Enterprise Value 0.195

HSIC Efficiency

Revenue/Employee 493,560.00
Income Per Employee 16,640.00
Receivables Turnover 6.623
Total Asset Turnover 1.287

HSIC Liquidity

Current Ratio 1.673
Quick Ratio 0.996
Cash Ratio 0.064

HSIC Profitability

Gross Margin 29.589
Operating Margin 5.787
Pretax Margin 4.393
Net Margin 3.371
Return on Assets 4.338
Return on Equity 11.717
Return on Total Capital 6.504
Return on Invested Capital 7.803

HSIC Capital Structure

Total Debt to Total Equity 74.993
Total Debt to Total Capital 42.855
Total Debt to Total Assets 25.925
Long-Term Debt to Equity 61.477
Long-Term Debt to Total Capital 35.131
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Henry Schein Inc. - HSIC

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
10.12B 12.40B 12.65B 12.34B
Sales Growth
+1.34% +22.55% +1.98% -2.44%
Cost of Goods Sold (COGS) incl D&A
7.30B 8.73B 9.00B 8.69B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
185.54M 209.53M 212.00M 248.00M
Depreciation
64.30M 70.40M 68.00M 70.00M
Amortization of Intangibles
121.24M 139.13M 144.00M 178.00M
COGS Growth
+5.94% +19.49% +3.08% -3.45%
Gross Income
2.81B 3.67B 3.65B 3.65B
Gross Income Growth
-8.95% +30.48% -0.63% +0.05%
Gross Profit Margin
+27.81% +29.61% +28.85% +29.59%
2020 2021 2022 2023 5-year trend
SG&A Expense
2.25B 2.82B 2.71B 2.94B
Research & Development
- - - -
-
Other SG&A
2.25B 2.82B 2.71B 2.94B
SGA Growth
-4.71% +25.39% -3.78% +8.34%
Other Operating Expense
- - - -
-
Unusual Expense
32.09M 3.15M 191.00M 126.00M
EBIT after Unusual Expense
535.30M 851.66M 747.00M 588.00M
Non Operating Income/Expense
5.97M 6.49M 18.00M 41.00M
Non-Operating Interest Income
9.84M 6.45M 17.00M 17.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
41.38M 27.60M 44.00M 87.00M
Interest Expense Growth
-18.54% -33.30% +59.42% +97.73%
Gross Interest Expense
41.38M 27.60M 44.00M 87.00M
Interest Capitalized
- - - -
-
Pretax Income
499.89M 830.55M 721.00M 542.00M
Pretax Income Growth
-26.52% +66.14% -13.19% -24.83%
Pretax Margin
+4.94% +6.70% +5.70% +4.39%
Income Tax
95.37M 197.35M 170.00M 120.00M
Income Tax - Current - Domestic
107.55M 165.58M 199.00M 100.00M
Income Tax - Current - Foreign
40.80M 42.75M 44.00M 40.00M
Income Tax - Deferred - Domestic
(22.92M) (14.68M) (61.00M) 6.00M
Income Tax - Deferred - Foreign
(30.06M) 3.70M (12.00M) (26.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
416.87M 653.21M 566.00M 436.00M
Minority Interest Expense
15.63M 29.29M 28.00M 20.00M
Net Income
401.24M 623.91M 538.00M 416.00M
Net Income Growth
-21.93% +55.50% -13.77% -22.68%
Net Margin Growth
+3.97% +5.03% +4.25% +3.37%
Extraordinaries & Discontinued Operations
- - - 986.00K
-
Discontinued Operations
- - - 986.00K
-
Net Income After Extraordinaries
402.22M 623.91M 538.00M 416.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
402.22M 623.91M 538.00M 416.00M
EPS (Basic)
2.8225 4.4536 3.954 3.1848
EPS (Basic) Growth
-17.86% +57.79% -11.22% -19.45%
Basic Shares Outstanding
142.50M 140.09M 136.06M 130.62M
EPS (Diluted)
2.8048 4.4008 3.9055 3.1575
EPS (Diluted) Growth
-17.59% +56.90% -11.25% -19.15%
Diluted Shares Outstanding
143.40M 141.77M 137.76M 131.75M
EBITDA
752.93M 1.06B 1.15B 962.00M
EBITDA Growth
-17.97% +41.36% +8.05% -16.35%
EBITDA Margin
+7.44% +8.58% +9.09% +7.80%

Snapshot

Average Recommendation HOLD Average Target Price 75.00
Number of Ratings 14 Current Quarters Estimate 1.229
FY Report Date 12 / 2024 Current Year's Estimate 4.776
Last Quarter’s Earnings 1.22 Median PE on CY Estimate N/A
Year Ago Earnings 4.50 Next Fiscal Year Estimate 5.208
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 13 11 13 13
Mean Estimate 1.23 1.19 4.78 5.21
High Estimates 1.26 1.25 4.81 5.42
Low Estimate 1.19 1.12 4.72 5.05
Coefficient of Variance 1.80 3.11 0.49 2.16

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 4
OVERWEIGHT 1 1 1
HOLD 6 6 7
UNDERWEIGHT 2 2 1
SELL 1 1 1
MEAN Hold Hold Hold

Insider Actions for Henry Schein Inc. - HSIC

Date Name Shares Transaction Value
Jun 12, 2024 Anne H. Margulies Director 19,570 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $68.51 per share 1,340,740.70
May 16, 2024 Stanley M. Bergman Chairman, CEO; Director 476,356 Bona fide gift 0.00
Mar 20, 2024 James P. Breslawski Vice Chairman, President; Director 209,562 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74.37 per share 15,585,125.94
Mar 12, 2024 Michael Saul Ettinger EVP & Chief Operating Officer 100,091 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2024 Mark E. Mlotek EVP, Chief Strategic Officer; Director 90,851 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2024 Bradford C. Connett CEO, NA Distribution Group 79,538 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2024 Ronald N. South SVP & Chief Financial Officer 69,933 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2024 Philip A. Laskaway Director 24,565 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $76.29 per share 1,874,063.85
Mar 6, 2024 Walter Siegel Sr. VP & Chief Legal Officer 43,660 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Steven Paladino Director 136,163 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $76.88 per share 10,468,211.44
Mar 6, 2024 James P. Breslawski Vice Chairman, President; Director 212,469 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $76.5 per share 16,253,878.50
Mar 6, 2024 Joseph L. Herring Director 24,904 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Lorelei McGlynn SVP, Chief Human Res. Officer 92,868 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Lorelei McGlynn SVP, Chief Human Res. Officer 80,302 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $76.88 per share 6,173,617.76
Mar 6, 2024 Kurt P. Kuehn Director 16,202 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Kurt P. Kuehn Director 13,598 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $77.07 per share 1,047,997.86
Mar 6, 2024 Scott Serota Director 5,941 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Bradley T. Sheares Director 42,774 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Bradley T. Sheares Director 40,170 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $76.88 per share 3,088,269.60
Mar 6, 2024 Deborah M. Derby Director 9,672 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Henry Schein Inc. in the News